Effect of metabolic syndrome on the prognosis of patients with acute myocardial infarction after percutaneous cor-onary intervention
GAO Yuan
GUO Liang
LI Xue-yuan
ZHANG Hai-shan
GUAN Qi-gang
LI Wen-na
QI Guo-xian
SUN Ying-xian
Abstract：Objective To evaluate the effect of metabolic syndrome ( MetS) on the incidence of in-hospital and long-term major adverse cardiac events (MACE) of acute myocardial infarction (AMI) patients treated with percutane-ous coronary intervention (PCI) .Methods This was a retrospective study.From May of 2011 to September of 2013, we consecutive enrolled 157 AMI patients with MetS in the First Affiliated Hospital of China Medical University into Group A, and 216 AMI patients without MetS into the control group ( Group B) .Incidence of both in-hospital and 12 months postoperative MACE were calculated.Results Compared with Group B, the incidence of MACE in Group A was higher both during hospitalization (7.01%vs 2.31%, P=0.027) and in the 12 months postopertive period (21.7% vs 12%, P=0.013).Cox proportional hazard regression analysis showed that MetS was a predictive factor of 12-month MACE (HR=2.65, 95%CI, 1.102~3.065, P=0.002).Conclusion The incidence of MACE for AMI patients with MetS after PCI during hospitalization and 12 months postoperatively were higher.MetS was a risk factor for poor prognosis.
Keywords：metabolic syndromeangioplastyacute myocardial infarction
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 2158-2160 )